| PERIOD ENDING | 31-May-09 | 28-Feb-09 | 30-Nov-08 | 31-Aug-08 | | Total Revenue | 1,051,343 | 876,129 | 970,967 | 831,397 | | Cost of Revenue | 400,202 | 373,290 | 377,296 | 362,269 | | | Gross Profit | 651,141 | 502,839 | 593,671 | 469,128 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 315,151 | 296,811 | 286,806 | 271,127 | | Non Recurring |
-
|
-
|
-
| (169,966) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 335,990 | 206,028 | 306,865 | 367,967 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 6,165 | 1,977 | 1,516 | 12,351 | | Earnings Before Interest And Taxes | 342,155 | 208,005 | 308,381 | 380,318 | | Interest Expense | 2,500 |
-
|
-
|
-
| | Income Before Tax | 339,655 | 208,005 | 308,381 | 380,318 | | Income Tax Expense | 139,043 | 82,929 | 128,073 | 151,094 | | Minority Interest | 492 | 270 | 52 | 369 | | | | Net Income From Continuing Ops | 201,104 | 125,346 | 180,360 | 229,593 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 201,104 | 125,346 | 180,360 | 229,593 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $201,104 | $125,346 | $180,360 | $229,593 |
|
0.45% Nasdaq 
0.20%
Income Statement
